Watchlist Sponsored By :
- 'Significant Weakness' Still Ahead: Fed's Hoenig
- Stronger Yuan Needed for Global Rebalancing: IMF Chief
- Japan Third Quarter GDP Jumps; 2010 Growth May Slow
- Quiz: How Much Do You Know About Green?
- Analysis: APEC Nations Back Face-Saving Climate Plan
- BlackRock: Central Banks To Be Net Buyers of Gold
- GM to Start Repaying $6.7 Billion US Government Loan
- Canon to Buy Dutch Oce in $2.2 Billion Deal
- Shift Into High-Quality Stocks Could Move Market Higher
- Warren Buffett to CNBC: 'I Haven't Bought American Express In Years'
- CNBC Video: Warren Buffett & Bill Gates - Keeping American Great
- U.S. Stocks Rally for the Second Straight Week
- Dollar is Not Plunging—So 'Calm Down': Market Strategist
- Strategists Say Markets Have More Upside — But How Much?
- Hirschhorn: Risk-Averse Traders
- Roginsky: A Funny Thing Happened on the Way to Financial Reform
- This Year's Biggest Thanksgiving Leftover: Cash
- TV Series Inks Unique Deal For Fight
MOST SHARED
- U.S. May Wind Up Green With Envy
- Warren Buffett to CNBC: 'I Haven't Bought American Express In Years'
- Japan Third Quarter GDP Jumps; 2010 Growth May Slow
- For Investors, The New Green Looks To Be White
- Analysis: APEC Nations Back Face-Saving Climate Plan
- Taking a Page from Obama's Asia Agenda in Investing
- CNBC Video: Warren Buffett & Bill Gates - Keeping American Great
- Stronger Yuan Needed for Global Rebalancing: IMF Chief
- Disaster Film '2012' Drowns Rivals at Box Office
- Sustainability Indices Sprouting Up
powered by digg
Glaxo Drug May Help Shrink Metastatic Brain Tumors
Topics:Pharmaceuticals
Companies:GlaxoSmithKline plc
Text Size 
Study results show the new oral drug Tykerb from GlaxoSmithKline, combined with chemotherapy, may shrink metastatic brain tumors.
The data presented Sunday at a breast cancer conference in San Antonio indicate that 20 percent of patients whose cancer had spread to their brain saw their brain tumors cut more than in half, and 37 percent of patients had them shrink 20 percent or more.
Experts say very few drugs have been shown to be able to get at brain metastases in patients with a certain type of advanced breast cancer.
The study, which Glaxo [GSK
Loading...
()
] paid for, was relatively small, and investigators say larger tests are needed.
© 2009 CNBC.com
Print
Email
- Where, what, how.
- Warren Buffett and Bill Gates spoke to Columbia students, and Buffett made the students a startling offer.
- For the chief of cable company Comcast, growth has been about making deals – generally very large deals.
- Some companies may start using insurance to shift carbon risk from their balance sheets to maybe... yours?
- The president and founder of Genesis Today wants to improve America’s health, and thinks Wal-Mart can help.
- Switzerland's privacy watchdog is taking legal action to force Google to make changes to its Street View service.
MORE FROM CNBC
Data is a real-time snapshot *Data is delayed at least 15 minutes